Clinical trials
Completed Phase 1 Metabolic Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lund University | 4 |
| Yungjin Pharm. Co., Ltd. | 3 |
| Philip Kern | 2 |
| Aphaia Pharma US LLC | 1 |
| Catholic University of the Sacred Heart | 1 |
| Fukuoka University | 1 |
| Inversago Pharma Inc. | 1 |
| Kowa Research Europe | 1 |
| Mayo Clinic | 1 |
| Mclean Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 31 |
| Obesity | 12 |
| Insulin Resistance | 3 |
| Prediabetic State | 3 |
| Hyperglycemia | 2 |
| Aneurysm | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Glucose Intolerance | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipidemia, Familial Combined | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.